Sternal Closure Systems Market Size, Share & Trends Report

Sternal Closure Systems Market Size, Share & Trends Analysis Report By Product (Closure Devices, Bone Cement), By Procedure (Median Sternotomy, Bilateral Thoracosternotomy), By Material, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Jan, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-2-68038-598-4
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 120

Report Overview

The global sternal closure systems market size was estimated at USD 1.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2021 to 2028. Expanding base of geriatric population undergoing open-heart surgery through median sternotomy is considered to be one of the primary factors driving the market for sternal closure systems. Median sternotomy procedure has remained the most popular technique for cardiac exposure till date, owing to easy and quick access to heart valves and vessels. Sternotomy and sternal closure occur prior to and post cardiac surgery, respectively.

Japan sternal closure systems market size, by product, 2016 - 2028 (USD Million)

A rise in the number of surgical procedures globally has driven demand for surgical instruments leading to the growth of the market for sternal closure systems. According to OECD, the estimated surgical procedures in 2012, were around 399,952 in the U.K. which later increased to 491,604 by 2016. Furthermore, lack of exercise and poor nutrition increase the risk of heart diseases in the elderly population. Furthermore, the growing geriatric population, which is more susceptible to chronic CVDs, is leading to an increase in the number of cardiovascular surgical procedures, thereby boosting the demand for sternal closure systems globally.

Moreover, developing countries are focusing on investing in public healthcare infrastructure due to the rise in non-communicable disease burden and injuries will further increase the number of surgical procedures in developing regions as well. According to data published by the world bank, in 2015, China's per capita healthcare expenditure was USD 425.6 accounting for 5.3% of GDP. Furthermore, the Plan of Health China 2030 estimates that by 2020 healthcare spending is expected to account for 6.5% to 7% of its total GDP.

COVID19 impact: The global market declined by 22% in 2020. However, the CAGR from 2021 to 2028 is expected to go beyond 10%

Pandemic Impact

Post COVID Outlook

Low and intermediate-level cases were delayed during the first peak of COVID-19.

The number of open-heart surgeries and the need for sternal closure systems is expected to accelerate from 2021 to 2024 owing to cardiac complications associated with COVID-19 recovered patients.

Ministry of Health and Family Welfare in India has advised restricting elective surgeries until further notification

The number of surgeries are slowly rising with institution-specific pathways for surgeries. The market is expected to normalize by mid-2022.

 

Furthermore, developing countries are focusing on investing in public healthcare infrastructure due to the rising non-communicable disease burden and injuries. This is projected to increase the number of surgical procedures in developing regions as well. According to data published by the World Bank, in 2015, China's per capita healthcare expenditure was USD 425.6, accounting for 5.3% of GDP. Furthermore, the Plan of Health China 2030 estimates that by 2020 healthcare spending is anticipated to account for 6.5% to 7% of its total GDP. Sedentary lifestyles, high smoking, and alcohol consumption, and unhealthy diet are leading to an increase in the prevalence of cardiac diseases globally. This is resulting in a rise in surgical procedures, which in turn, is likely to fuel the adoption of sternal closure systems in surgeries over the coming years. According to a survey conducted by the Centers for Disease Control and Prevention, in 2016, 28.1 million adults in the U.S. were diagnosed with heart disease.

Product Insights

The closure devices segment dominated the market for sternal closure systems and accounted for the highest revenue share of 71.5% in 2020. Factors such as the launch of products coupled with rising per capita expenditure in developed as well as developing economies are key factors responsible for the dominant share of the segment. These devices have demonstrated benefits such as a decrease in postoperative complications and infections along with faster recovery time in comparison with bone cement. Moreover, rising efforts being taken by key players in the market for sternal closure systems to introduce new techniques and product lines are likely to further boost the segment growth in the near future.

Key products in this segment include SternaLock Blu and SternaLock 360 by Zimmer Biomet; Sternal ZIPFIX System by DePuy Synthes; and Sternal Talon Implants by KLS Martin Group. Companies operating in the market for sternal closure systems are focusing on R&D to deliver advanced solutions. For instance, Orthofix Holdings, Inc., a U.S. based company engaged in R&D and marketing of orthopedic products, has invested USD 28.8 million and USD 29.7 million during FY 2017 and FY 2018, respectively. In January 2017, JACE Medical, LLC has launched pre-monoblock sternal plates in the U.S. These plates are used prior to the surgery and work as implant positioner.

Material Insights

The titanium segment dominated the market for sternal closure systems and account for the largest revenue share of 42.9% in 2020. This dominance is due to the associated benefits such as corrosion-resistant, ability to effectively join human bones, and biocompatibility of titanium. In addition, non-ferromagnetic property, which allows patients with titanium implants to examine safely under Magnetic resonance imaging (MRI) scan, is further enhancing penetration of the material in the industry.

Furthermore, the high efficacy, non-toxic nature of implant and stability of the titanium products, greater economic feasibility coupled with increased affordability for the use of advanced titanium clips and plates in developed as well as developing regions, are projected to bolster the penetration of titanium-based sternal closure systems. The Polyether Ether Ketone (PEEK) segment is expected to grow at the highest rate over the forecast period owing to technological advancements, growing R&D investments by key players, and biocompatible properties of the material.

Procedure Insights

The median sternotomies segment dominated the sternal closure systems market and accounted for the highest revenue share of 50.7% in 2020. Median sternotomies are frequently performed osteotomies worldwide, as the procedure provides easy access to the heart, lungs, and surrounding structures during heart valve replacement surgery and coronary artery bypass surgery. Median sternotomies also reduce post-operative infections and complications thereby further increasing its demand globally.

Global sternal closure systems market share, by procedure, 2020 (%)

The growing geriatric population, prone to develop chronic cardiac disorders such as CVDs is anticipated to fuel demand for median sternotomy procedures. The geriatric population worldwide is anticipated to double in near future. According to a report by the United Nations Department of Economic and Social Affairs (2015), the number of people aged over 60 years is expected to grow by 56.0% from 2015 to 2030. The geriatric population was 901 million in 2015 and anticipated to reach 2.1 billion by 2050.

Regional Insights

North America dominated the market for sternal closure systems and accounted for the largest revenue share of 35.0% in 2020 and is expected to continue its dominance over the forecast period. Rising collaborative efforts commenced by key players to improve their product offerings and ensure high-quality standards is further anticipated to boost the demand for systems across the region. For instance, in August 2017, A&E Medical Corporation acquired RTI Surgical’s Cardiothoracic Closure business. RTI Surgical’s Cardiothoracic Closure business offers cable-based plate products such as Tritium SPC System. Moreover, the major share for North America can also be attributed to the high cardiac disease burden in this region. For instance, according to the study conducted by the CDC, around 28.1 million people in the U.S. have diagnosed with heart-related disorders such as cardiac arrest and valvular heart disease. In addition, favorable reimbursement regulations are expected to further fuel the growth of the market for sternal closure systems. As per the revised wound closure Medicare reimbursement coding guide, sternal closure procedures are reimbursed under 216, 217, 218, 219, 220, 221, 228, and 229 MS-DRG codes from 2018.

On the other hand, Asia Pacific is expected to witness a lucrative CAGR over the coming years as key players are increasing their geographical presence in the region and focusing on the commercialization of their product at a relatively affordable price. For instance, in June 2016, the KLS Martin Group started its operations in Chennai, India in an attempt to seize the growing opportunity. Moreover, growing healthcare expenditure and infrastructure facilities coupled with growing awareness about cardiac diseases and treatment availability will further fuel the growth of the market for sternal closure systems in the region.

Key Companies & Market Share Insights

Product launch, strategic acquisitions, and innovation are the major strategies adopted by the market players to retain their share in the market for sternal closure systems. In September 2019, DePuy Synthes launched CONDUIT interbody Platform with EIT cellular titanium technology to expand its product portfolio of degenerative spine diseases. In October 2018, Zimmer Biomet launched Vitality+ and Vital Spinal Fixation Systems in the U.S. The Vital Spinal Fixation System offers solutions for degenerative thoracolumbar procedures. Some of the prominent players in the sternal closure systems market include:

  • Zimmer Biomet

  • Johnson & Johnson

  • B. Braun Melsungen AG

  • Orthofix Holdings, Inc.

  • GE Healthcare

  • KLS Martin Group

  • A&E Medical Corporation

  • Jace Medical, LLC

  • Acute Innovations

  • Abyrx, Inc.

  • Kinamed Incorporated      

Sternal Closure Systems Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 2.4 billion

Revenue forecast in 2028

USD 3.5 billion

Growth Rate

CAGR of 5.6% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

Product, procedure, material, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Brazil; Mexico; South Africa

Key companies profiled

Zimmer Biomet; Johnson & Johnson; B. Braun Melsungen AG; Orthofix Holdings, Inc.; GE Healthcare; KLS Martin Group; A&E Medical Corporation; Jace Medical, LLC; Acute Innovations; Abyrx, Inc.; Kinamed Incorporated

Customization Scope

Free report customization (equivalent to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global sternal closure systems market report based on the product, procedure, material, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Closure Devices

      • Sternal Closure Wires

      • Sternal Closure Plates and Screws

      • Sternal Closure Clips

      • Sternal Closure Cables

    • Bone Cement

  • Procedure Outlook (Revenue, USD Million, 2016 - 2028)

    • Median Sternotomy

    • Hemisternotomy

    • Bilateral Thoracosternotomy

    • Others

  • Material Outlook (Revenue, USD Million, 2016 - 2028)

    • Titanium

    • Polyether Ether Ketone (PEEK)

    • Stainless Steel

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.